UC professor honored for medical device work
UC professor of mechanical engineering Rupak Banerjee was recently inducted to the American Institute for Medical and Biological Engineering’s College of Fellows.
University of Cincinnati professor Rupak Banerjee was inducted last week to the American Institute for Medical and Biological Engineering’s College of Fellows. The College of Fellows comprises the top 2 percent of medical and biological engineers and distinguishes those who pioneer new and developing fields of technology.
The honor reflects the innovation agenda platform of UC’s strategic direction, Next Lives Here.
Banerjee, a professor in UC’s Department of Mechanical Engineering and Materials Sciences, directs the Transport in Engineering and Medicine Laboratory. The lab’s mission is to connect patient diagnoses with bio-transport assessment.
Banerjee and his collaborators develop diagnostic endpoints and design devices that detect and treat pathophysiologic conditions, like small and large artery diseases and valvular dysfunction, in the heart. They also use novel devices like high-intensity ultrasound to ablate tumors, microneedle implants to treat ocular diseases and microfluidic devices to detect pathogens in biological fluids.
Under the direction of Banerjee, the team collaborates across disciplines and colleges to successfully treat these biological systems.
“Most of these projects have fluid, heat and mass transfer as their core principle,” said Banerjee. “But they all involve multidisciplinary systems to be successful.”
Banerjee and the lab enhance the quality of life through medical breakthroughs, only one reason why UC is at the forefront of innovation and discovery. The recent honor by the American Institute for Medical and Biological Engineering recognizes these efforts.
Bending the Future
The University of Cincinnati is the region's destination for thinking, making, doing, discovery and delivery. Next Lives Here.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.
Combination immunotherapy helps overcome melanoma treatment resistance
November 10, 2025
MSN highlighted research led by the University of Cincinnati Cancer Center's Trisha Wise-Draper showing a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.